Yue (Cindy) Yang, PhD

Highlights

1
Nature metabolism · 2020
Y(Yue (Cindy) Yang
PMID: 32694608PMCID: PMC7384296DOIFirst author73 citations
2
International journal of molecular sciences · 2023
Y(Yue (Cindy) Yang
PMID: 37446292PMCID: PMC10342116DOISenior author15 citations
3
Metabolism: clinical and experimental · 2024
ARAndrew RappaLALaura Alonso Y(Yue (Cindy) Yang
PMID: 39710001PMCID: PMC11788054DOISenior author6 citations

25

4 grants

PI
The Role of NAD+ Metabolism in Obesity-Induced Pancreatic Beta-Cell Dysfunction
National Institute of Diabetes and Digestive and Kidney Diseases · 2025–2030
R01DK143009-02
Co-I
Mechanisms of Obesity-induced Atrial Fibrillation
National Heart, Lung, and Blood Institute · 2025–2028
R01HL177651-01
PI
Biopharma Agreement- Yue Yang and Metro Mid-Atlantic Biotech, LLC
Metro Mid-Atlantic Biotech, LLC · 2024–2027BioPharma Alliance
BP 243332-01
PI
NAD Metabolism in Aging and Disease: Dysfunction and Intervention
National Institute on Aging · 2020–2027
R01AG066192-05A1

Completed grants (4)

PI
Development of Novel, First-in-Class Therapeutics to Correct and Augment NAD Homeostasis
Metro Mid-Atlantic Biotech, LLC · 2021–2023BioPharma Alliance
BP 214691-01
PI
Mechanisms of AHR Metabolic Toxicity
National Institute of Environmental Health Sciences · 2017–2023
R01ES027488-05
KP
NAD-Augmenting Agents to Enhance Neural Survival and Function Following Spinal Cord Injury
New York State Department of Health · 2017–2019
DOH01-C32098GG-34500
KP
Nicotinamide Riboside and NAD+: Modulation of Sirtuins and Reactive Oxygen
National Institute of General Medical Sciences · 2013–2019
R01GM106072-03